LANXESS has completed the acquisition of Itibanyl Produtos Especiais Ltda. (IPEL). The competent anti-trust authorities approved the transaction beginning of January.
Strengthens Biocides Business
With the acquisition, LANXESS is strengthening its position as one of the world’s leading manufacturers of
antimicrobial active ingredients and formulations. In addition to around 100 employees and the production facility, LANXESS has taken over the Brazilian company’s laboratory facilities.
IPEL generates most of its sales with
biocides and specialty chemicals for the paint and coating industry. The product portfolio also includes preservatives and fungicides for process control in water treatment as well as active ingredients for disinfection and cleaning agents.
The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
IPEL is one of Brazil’s leading
biocide manufacturers and generated sales in the lower double-digit million-euro range in 2018.
Source: LANXESS